Listen Live
Donate
 on air
    Schedule

    KCRW

    Read & Explore

    • News
    • Entertainment
    • Food
    • Culture
    • Events

    Listen

    • Live Radio
    • Music
    • Podcasts
    • Full Schedule

    Information

    • About
    • Careers
    • Help / FAQ
    • Newsletters
    • Contact

    Support

    • Become a Member
    • Become a VIP
    • Ways to Give
    • Shop
    • Member Perks

    Become a Member

    Donate to KCRW to support this cultural hub for music discovery, in-depth journalism, community storytelling, and free events. You'll become a KCRW Member and get a year of exclusive benefits.

    DonateGive Monthly

    Copyright 2026 KCRW. All rights reserved.

    Report a Bug|Privacy Policy|Terms of Service|
    Cookie Policy
    |FCC Public Files|

    Back to To the Point

    To the Point

    Generic Cipro: Cost to Consumers, Research

    With the US under bio-terrorist attack, germs have become weapons of war. Combating them requires drugs and vaccines, which has made the pharmaceutical companies a de facto part of the nation's defenses. Canada has begun stockpiling generic forms of Cipro, even though Bayer still holds the patent, and drug companies are responding with claims that such "enlistment" places them in economic jeopardy. We look at profits and patriotism, anthrax, antibiotics and national defense, with health care experts, ethicists and the pharmaceutical industry. Newmaker: Snail Mail Could Further Disrupt US Economy - Already facing its worst year in recent history, the US Postal Service now finds itself on the front line of the anthrax attacks. Greg Ip, of The Wall Street Journal, looks at new attention being focused on the importance of "snail mail" to the nation's economy, and discusses potentially devastating disruptions to business and cash flow. Reporter's Notebook: Yankees Win One for New York - The New York Yankees have won so many baseball titles, one could believe their winning were part of God's natural order of things. Last night, they won the pennant again for the fourth year in a row. Pete Hamill, columnist for the New York Daily News, calls their victory a "return to normalcy."

    • rss
    • Share
    By Warren Olney • Oct 23, 2001 • 1 min read

    With the US under bio-terrorist attack, germs have become weapons of war. Combating them requires drugs and vaccines, which has made the pharmaceutical companies a de facto part of the nation's defenses. Canada has begun stockpiling generic forms of Cipro, even though Bayer still holds the patent, and drug companies are responding with claims that such "enlistment" places them in economic jeopardy. We look at profits and patriotism, anthrax, antibiotics and national defense, with health care experts, ethicists and the pharmaceutical industry.

    • Newmaker:

      Snail Mail Could Further Disrupt US Economy - Already facing its worst year in recent history, the US Postal Service now finds itself on the front line of the anthrax attacks. Greg Ip, of

      The Wall Street Journal, looks at new attention being focused on the importance of "snail mail" to the nation's economy, and discusses potentially devastating disruptions to business and cash flow.

    • Reporter's Notebook:

      Yankees Win One for New York - The New York Yankees have won so many baseball titles, one could believe their winning were part of God's natural order of things. Last night, they won the pennant again for the fourth year in a row. Pete Hamill, columnist for the

      New York Daily News, calls their victory a "return to normalcy."

    US Postal Service

    American Public Health Association

    Apotex Group

    Bayer Pharmaceuticals

    Center for Business Ethics

    Center for Pharmaceutical Marketing and Management

    Elements of Pharmaceutical Pricing

    Local Insights, Global Ethics for Business

    New York Daily News

    New York Yankees

    • https://images.ctfassets.net/2658fe8gbo8o/AvYox6VuEgcxpd20Xo9d3/769bca4fbf97bf022190f4813812c1e2/new-default.jpg?h=250

      Warren Olney

      former KCRW broadcaster

      NewsNationalPolitics
    Back to To the Point